4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-056534
President & CEO sold 83,333 shares at $24.20 ($2,016,659)
- President & CEO acquired 83,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…